<DOC>
	<DOCNO>NCT02143323</DOCNO>
	<brief_summary>This study open-label , one-sequence , multiple drug administration design . The purpose study follow ; - To evaluate change liver function accord glutathione s-transferase ( GST ) genotype multiple administration amoxicillin/clavulanate . - To evaluate intrinsic metabolite , human leukocyte antigen ( HLA ) genotype , microRNA ( miRNA ) base liver function change candidate biomarker DILI .</brief_summary>
	<brief_title>A Clinical Study Explore Biomarkers Drug-induced Liver Injury ( DILI )</brief_title>
	<detailed_description />
	<mesh_term>Drug-Induced Liver Injury</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<criteria>1 . Subject sufficient ability understand nature study hazard participate . Provide write informed consent fully inform study procedures 2 . Healthy male female subject age 20 45 year 3 . Subjects whose body mass index ( BMI ) range 18.5 kg/m2 ( inclusive ) 27 kg/m2 ( exclusive ) 1 . Subject clinically significant disease liver , kidney , nerve system , respiratory system , endocrine system , blood , tumor , urinary system , cardiovascular system , mental disease medical history 2 . Subject take prescribed drug , herbal agent crude drug within 2 week study drug administration 3 . Subject blood donation 1 month study Blood donation 2 month study 4 . Subject presence history severe adverse reaction study drug 5 . Subject prevent pregnancy study period . 6 . Female subject pregnant . 7 . Subject drank 21 units/week alcohol subject would able stop drinking alcohol hospitalization 8 . Subject Heavy smoker 10 cigarettes/day within 3 month prior screen subject would able stop smoking hospitalization . 9 . Subject judge eligible study participation investigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>GST , DILI , biomarker</keyword>
</DOC>